Pembrolizumab plus lenvatinib vs chemotherapy and lenvatinib monotherapy for recurrent/metastatic head and neck squamous cell carcinoma that progressed on platinum therapy and immunotherapy: LEAP-009

被引：0

作者：

Harrington, Kevin J. ^{[1
]}

Cohen, Ezra E. W. ^{[2
,3
]}

Siu, Lillian ^{[4
]}

Rischin, Danny ^{[5
]}

Licitra, Lisa ^{[6
,7
]}

Vermorken, Jan ^{[8
]}

Quynh Le ^{[9
]}

Tahara, Makoto ^{[10
]}

Machiels, Jean-Pascal ^{[11
]}

Hawk, Natalyn ^{[12
]}

Ge, Joy ^{[13
]}

Bidadi, Behzad ^{[13
]}

Swaby, Ramona F. ^{[13
]}

Burtness, Barbara ^{[14
]}

机构：

[1] Inst Canc Res, London, England

[2] Univ Calif San Diego, La Jolla, CA 92093 USA

[3] Moores Canc Ctr, La Jolla, CA USA

[4] Univ Hlth Network, Toronto, ON, Canada

[5] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[6] Fdn IRCCS Ist Nazl Tumori, Milan, Italy

[7] Univ Milan, Milan, Italy

[8] Antwerp Univ Hosp, Edegem, Belgium

[9] Stanford Univ, Stanford, CA 94305 USA

[10] Natl Canc Ctr Hosp, Kashiwa, Chiba, Japan

[11] Clin Univ St Luc, Brussels, Belgium

[12] Eisai Inc, Woodcliff Lake, NJ USA

[13] Merck & Co Inc, Kenilworth, NJ USA

[14] Yale Canc Ctr, New Haven, CT USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-94

引用

页数：2